Sign Out
Hypersensitivity to the active substance or to any of the excipients of the product.
Concomitant administration of cytochrome P450 3A4 inhibitors, such as HIV-protease inhibitors, azole-antifungal agents, erythromycin, clarithromycin and nefazodone (see also Interactions).
